LEGN
Legend Biotech Corp
NASDAQ · Healthcare · Biotechnology · US
$22.77
+6.01%Forward multiples
Based on analyst estimates
- P/E forward
- 38.99x
- P/E 2026E
- —
- P/E 2027E
- 40.68x
- P/E 2028E
- 21.86x
- P/S forward
- 2.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.60x
- Price / sales
- 3.48x
- Price / cash flow
- -24.19x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 2.94x
- EV / EBITDA
- 1820.08x
- EV / EBIT
- -66.64x
- Market cap
- $4.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026